Buti M, Ledesma F, Domínguez-Hernández R, Casado MÁ, Esteban R
Is the universal population hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Rico S, Echave M, Casado MA, Soto J
Systematic review of economic evaluations based on decisión-analytic modeling of cancer drugs
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Peral C, Navarro F, Montoro M, Balsa A, Gomez S, Pablos J, Martinez-Sesmero JM, Valderrama M, Oyagüez I, de Andrés-Nogales F, Casado MÁ
Cost-effectiveness of tofacitinib-containing sequences for rheumatoid arthritis patients in Spain
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Marco A, Domínguez-Hernández R, Casado MA
Clinical and economic impact of the treatment of chronic hepatitis C in prison inmates in Spain
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
de Andrés-Nogales F, Oyagüez I, Morell A, Casado MÁ
Cost analysis of botulinum toxin A (Botox® and Xeomin®) in real-world clinical practice
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
García F, Domínguez-Hernández R, Alados JC, Casado M, Macías J, Téllez F, Pascasio JM, Casado MA
Healthcare outcomes of one-step diagnosis in patients with chronic hepatitis C
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Llamas-Velasco M, Sánchez-Pérez J, Pardo J, Cabeza-Martínez R, Miranda Fontes M, Márquez J, Armesto S, Belinchón I, Castañeda S, Casado A, Amaro A, Yébenes M, Sabater E, COEPSO Study Group
Patient’s preferences for psoriasis treatment based on a discrete choice experiment. COEPSO study
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Castañeda S, Vicente-Rabaneda EF, Calvo-Alén J, Gómez A, Miranda MD, Martínez Pardo S, Merino L, Llamas-Velasco M, Casado A, Amaro A, Sabater E, Yébenes M, COEPSO Study Group
Patient’s preferences for treatment of psoriatic arthritis based on a discrete choice experiment. Results of the COEPSO study
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Capel M, Ciudin A, Mareque M, Rodríguez-Rincón RM, Oyagüez I
Cost-effectiveness analysis of exenatide versus GLP-1 receptor agonists in patients with type 2 Diabetes Mellitus
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Casado MA, de Andrés-Nogales F, Ignacio E, Ortiz P, Peralta G, Poveda JL, Ruiz Moreno JM, Sabater E, Trillo JL, Zarranz-Ventura J, Grupo MULTIDEX-EMD
A Multi-Stakeholder Multicriteria decision analysis in Diabetic Macular Edema. MULTIDEX-EMD Study
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018